Warning: Attempt to read property "taxonomy" on null in /srv/users/projectals/apps/projectals-prod/public/wp-content/plugins/seo-by-rank-math/includes/frontend/paper/class-taxonomy.php on line 49
Warning: Attempt to read property "taxonomy" on null in /srv/users/projectals/apps/projectals-prod/public/wp-content/plugins/seo-by-rank-math/includes/frontend/paper/class-taxonomy.php on line 54
Warning: Attempt to read property "taxonomy" on null in /srv/users/projectals/apps/projectals-prod/public/wp-content/plugins/seo-by-rank-math/includes/class-term.php on line 110 Skip to content
Project ALS Announces Research Advisory Board 2.0 Non-Profit ALS Research Leader Gathers a Diversity of Expertise to Guide Next-Phase Progress (New York, NY)
On Wednesday, Amylyx Pharmaceuticals announced that they are planning to file a New Drug Application—the formal submission for a drug to be approved by the
Prosetin is moving to Phase I clinical trials. View the recording of our live conversation with clinical trial specialist Jinsy Andrews, MD, MSc and regulatory